albuterol has been researched along with Extravasation of Contrast Media in 2 studies
Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Auais, A | 1 |
Wedde-Beer, K | 1 |
Piedimonte, G | 1 |
Kwan, ML | 1 |
Gómez, AD | 1 |
Baluk, P | 1 |
Hashizume, H | 1 |
McDonald, DM | 1 |
2 other studies available for albuterol and Extravasation of Contrast Media
Article | Year |
---|---|
Anti-inflammatory effect of albuterol enantiomers during respiratory syncytial virus infection in rats.
Topics: Administration, Inhalation; Aerosols; Albumins; Albuterol; Animals; Anti-Inflammatory Agents; Diseas | 2005 |
Airway vasculature after mycoplasma infection: chronic leakiness and selective hypersensitivity to substance P.
Topics: Albuterol; Animals; Bronchodilator Agents; Capillary Permeability; Chronic Disease; Dose-Response Re | 2001 |